T37.4X6D Underdosing of anthelminthics, subsequent encounter

Name of the Condition

• Underdosing of anthelminthics, subsequent encounter

Summary

This condition refers to insufficient dosing of anthelminthic medications during a subsequent encounter for the effects of underdosing. Anthelminthics are used to treat parasitic worm infections, and underdosing may result in incomplete treatment or persistent infection. The "subsequent encounter" modifier indicates ongoing care for the underdosing effects, rather than the initial episode.

Causes

Underdosing can occur due to subtherapeutic dosing, patient non-adherence, formulation errors, or inadequate monitoring of treatment response. It may also result from incorrect administration, such as missed doses or improper timing, leading to reduced drug efficacy.

Risk Factors

• Patient non-adherence to prescribed regimens.
• Inadequate dosing adjustments for weight, age, or renal/hepatic function.
• Lack of follow-up to assess treatment efficacy.
• Concurrent medications that interfere with anthelminthic absorption or metabolism.

Symptoms

• Persistent or recurrent parasitic infection symptoms (e.g., abdominal pain, diarrhea, or visible worms).
• Failure to improve despite treatment.
• Signs of unresolved infection, such as eosinophilia or positive stool tests.
• No acute toxicity, as underdosing focuses on insufficient therapeutic effect.

Diagnosis

Clinical evaluation includes medication history, adherence assessment, and repeat diagnostic tests (e.g., stool samples, blood tests) to confirm persistent infection. Lab results may show ongoing parasitic activity, and imaging or physical exams may reveal unresolved infection-related complications.

Treatment Options

• Adjusting the anthelminthic dose or regimen to achieve therapeutic levels.
• Reinforcing patient education on proper administration and adherence.
• Repeating diagnostic testing to confirm resolution of infection.
• Addressing underlying barriers to adherence (e.g., cost, access, or understanding).

Prognosis and Follow-Up

Prognosis depends on timely dose correction and resolution of the underlying infection. Follow-up care is essential to monitor for treatment response and prevent recurrence. Most patients recover fully with appropriate dose adjustments, but delays may prolong infection or lead to complications.

Complications

• Persistent or worsening parasitic infection.
• Spread of infection to other organs or individuals.
• Increased risk of drug resistance if underdosing is prolonged.
• Delayed recovery or additional treatment cycles.

Lifestyle & Prevention

• Ensuring clear communication about dosing schedules and importance of adherence.
• Using reminder systems (e.g., alarms, pill organizers) to avoid missed doses.
• Addressing barriers to medication access or understanding.
• Educating patients on recognizing signs of treatment failure (e.g., unresolved symptoms).

When to Seek Professional Help

Seek care if symptoms persist or worsen after starting treatment, or if new symptoms (e.g., severe abdominal pain, fever, or dehydration) develop. Prompt evaluation is needed to adjust therapy and prevent complications.

Tips for Medical Coders

Use this code for subsequent encounters related to underdosing of anthelminthics. Document the reason for the encounter (e.g., follow-up for unresolved infection) and any dose adjustments or treatment modifications. Ensure the encounter is not the initial episode of underdosing, as that would use a different code.